Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
3.490
+0.380 (12.22%)
At close: Jun 26, 2026, 4:00 PM EDT
3.460
-0.030 (-0.86%)
After-hours: Jun 26, 2026, 7:50 PM EDT

Company Description

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.

The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.

It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp.
Embecta logo
Country United States
Founded 1924
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 1,850
CEO Devdatt Kurdikar

Contact Details

Address:
300 Kimball Drive, Suite 300
Parsippany, New Jersey 07054
United States
Phone 862 401 0000
Website embecta.com

Stock Details

Ticker Symbol EMBC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001872789
CUSIP Number 29082K105
ISIN Number US29082K1051
Employer ID 87-1583942
SIC Code 3841

Key Executives

Name Position
Devdatt Kurdikar Ph.D. President, Chief Executive Officer and Chairman
Jacob P. Elguicze Senior Vice President and Chief Financial Officer
Jeffrey Z. Mann Senior Vice President, General Counsel, Head of Business Development and Corporate Secretary
Jean M. Casner Senior Vice President and Chief Human Resources Officer
Shaun Curtis Senior Vice President of Global Manufacturing and Supply Chain
Anthony M. Roth Vice President, Chief Accounting Officer and Corporate Controller
Pravesh Khandelwal Vice President and Head of Investor Relations
Ginny Blocki Senior Vice President of Strategy
Tom Blount Senior Vice President and President of North America
Slobodan Radumilo Senior Vice President and President of International

Latest SEC Filings

Date Type Title
May 27, 2026 SCHEDULE 13G/A Filing
May 22, 2026 SD Form - SD
May 15, 2026 8-K Current Report
May 5, 2026 SCHEDULE 13G Filing
May 5, 2026 10-Q Quarterly Report
May 5, 2026 8-K Current Report
May 1, 2026 SCHEDULE 13G/A Filing
Apr 29, 2026 SCHEDULE 13G Filing
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 20, 2026 8-K Current Report